OrbiMed Capital GP VII LLC, 10% Owner at Passage BIO, Inc. (PASG), bought 369,100 shares at $5.42 ($2.0M) on 2022-01-20, disclosed to the SEC on 2022-01-24.
Open-market purchase of $2.0M PASG by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| PASG | SELL | 2024-12-26 | $276K | — | Filing → |
| PASG | SELL | 2024-12-06 | $77K | — | Filing → |
| PASG | SELL | 2024-09-18 | $147K | — | Filing → |